What Are Amphetamines and Barbiturates: Key Differences

Amphetamines and barbiturates are two classes of drugs that act on the central nervous system in opposite ways. Amphetamines are stimulants that speed up brain activity, while barbiturates are sedatives that slow it down. Both have legitimate medical uses, both carry significant risks for misuse, and both are classified as controlled substances in the United States.

What Amphetamines Do

Amphetamines work by flooding the brain with signaling chemicals, particularly dopamine and norepinephrine. Normally, nerve cells release these chemicals in controlled amounts and then reabsorb them. Amphetamines disrupt that recycling process in two ways: they force extra dopamine and norepinephrine out of storage inside nerve cells, and they block those chemicals from being pulled back in. The result is a surge of stimulation that increases alertness, focus, energy, and mood.

This stimulant effect is why amphetamines have FDA-approved medical uses. Doctors prescribe them primarily for ADHD, where they help regulate attention and impulse control. They’re also approved for narcolepsy (a sleep disorder that causes sudden daytime sleep attacks) and, in some formulations, for obesity and binge-eating disorder. A closely related compound, lisdexamfetamine, is specifically approved for ADHD and binge-eating disorder. Even methamphetamine has a narrow FDA approval for ADHD, though it is rarely prescribed.

What Barbiturates Do

Barbiturates do the opposite. They enhance the activity of GABA, the brain’s main calming chemical. When GABA attaches to its receptor on a nerve cell, it opens a channel that lets negatively charged particles flow in, making the cell less likely to fire. Barbiturates amplify and prolong that process, so the brain’s overall electrical activity slows down. At higher concentrations, barbiturates can activate these receptors directly, without GABA’s help, which is one reason they’re so potent and dangerous in large doses. They also block the brain’s excitatory signals by interfering with glutamate receptors, adding a second layer of sedation.

Barbiturates were once widely prescribed for anxiety, insomnia, and seizures. Today their medical role has narrowed considerably. Phenobarbital remains in use for seizure management, status epilepticus (prolonged seizure emergencies), and alcohol or benzodiazepine withdrawal. Short-acting barbiturates are sometimes used to induce anesthesia before surgery. Another barbiturate, primidone, is prescribed for seizure disorders and essential tremor. But for most conditions where barbiturates were once standard, safer alternatives like benzodiazepines have largely replaced them.

Side Effects of Amphetamines

Because amphetamines rev up the nervous system, their side effects tend to reflect overstimulation. Common effects include increased heart rate, elevated blood pressure, decreased appetite, weight loss, restlessness, tremors, and difficulty sleeping. These can range from mild nuisances at prescribed doses to serious problems at higher ones.

The cardiovascular risks are the most medically concerning. Amphetamines can cause irregular heartbeat and, in severe cases, heart attack. High body temperature and skin flushing occur because the drugs push the body’s thermostat upward. On the psychological side, heavy or prolonged use can trigger aggressive behavior, depression, hallucinations, and difficulty distinguishing what’s real from what isn’t. Chronic methamphetamine use is associated with severe dental decay (often called “meth mouth”), skin sores from compulsive picking, memory loss, and stroke.

Side Effects of Barbiturates

Barbiturate side effects reflect their depressant nature. At therapeutic doses, they cause drowsiness, impaired coordination, slurred speech, and confusion. These effects can make driving or operating machinery dangerous even at prescribed levels.

The serious risks escalate quickly with dose. Barbiturates suppress the brain’s breathing center, which means taking too much can slow or stop respiration entirely. They also cause blood pressure to drop and body temperature to fall. In toxicity, the progression runs from heavy sedation to coma, from slowed breathing to complete respiratory failure, and from low blood pressure to cardiovascular collapse. This spectrum of effects is what makes barbiturate overdose so lethal.

Why Barbiturates Are Considered More Dangerous

One of the key reasons barbiturates fell out of favor is their narrow therapeutic window, meaning the gap between a dose that works and a dose that kills is uncomfortably small. With benzodiazepines, which replaced barbiturates for most uses, overdose is far less likely to stop breathing on its own. Barbiturates don’t offer that margin of safety. Combining them with alcohol or other sedatives narrows the window even further.

Barbiturates also have long half-lives, meaning they stay active in the body for extended periods. This makes it easy to accumulate dangerous levels if doses are taken too close together. Clinicians who still use barbiturates in specific situations, like severe alcohol withdrawal, do so cautiously because of these risks.

Legal Classification

Both drug classes are controlled substances under federal law, but their scheduling varies by specific compound. Amphetamine and its brand-name formulations (such as Adderall and Dexedrine) are Schedule II, the category reserved for drugs with accepted medical use but high potential for abuse and dependence. Methamphetamine is also Schedule II. Several barbiturates, including amobarbital and pentobarbital, share that Schedule II classification. Phenobarbital, which has a somewhat lower abuse profile, is classified as Schedule IV.

Schedule II drugs can only be dispensed with a written prescription from a licensed provider, and refills are not permitted without a new prescription. Schedule IV drugs have slightly less restrictive rules but still require a prescription and carry legal penalties for unauthorized possession or distribution.

How They Compare at a Glance

  • Brain effect: Amphetamines increase dopamine and norepinephrine activity, speeding up brain function. Barbiturates enhance GABA activity, slowing it down.
  • Medical uses: Amphetamines treat ADHD, narcolepsy, and in some cases obesity or binge-eating disorder. Barbiturates treat seizures, are used in anesthesia, and help manage severe withdrawal syndromes.
  • Main risks: Amphetamines carry cardiovascular and psychiatric risks. Barbiturates carry respiratory depression and overdose risks.
  • Current prescribing trends: Amphetamines remain widely prescribed, especially for ADHD. Barbiturates have been largely replaced by safer alternatives and are now used in limited clinical situations.
  • Dependence potential: Both classes can produce physical dependence and withdrawal symptoms. Barbiturate withdrawal is particularly dangerous and can include seizures.

Despite working in opposite directions on the nervous system, amphetamines and barbiturates share a common thread: both powerfully alter brain chemistry, both carry real risks of dependence, and both require careful medical oversight when used therapeutically. Their divergent trajectories in modern medicine reflect how that risk calculus has played out. Amphetamines found a stable niche because no equally effective alternatives exist for conditions like ADHD. Barbiturates lost theirs because safer sedatives could do most of the same jobs without the same danger of fatal overdose.